D. E. Shaw & Co., Inc. Solid Biosciences Inc. Transaction History

D. E. Shaw & Co., Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.69 - $2.46 $33,271 - $48,430	-19,687 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.38 - $3.77 $115,201 - $182,483	-48,404 Reduced 71.09%	19,687 $47,000
Q2 2021 Aug 16, 2021	BUY	$3.49 - $5.51 $180,111 - $284,360	51,608 Added 313.1%	68,091 $249,000
Q1 2021 May 17, 2021	SELL	$5.37 - $10.72 $1.13 Million - $2.25 Million	-209,886 Reduced 92.72%	16,483 $91,000
Q4 2020 Feb 16, 2021	SELL	$3.08 - $7.79 $206,862 - $523,199	-67,163 Reduced 22.88%	226,369 $1.72 Million
Q3 2020 Nov 16, 2020	SELL	$2.02 - $3.08 $131,098 - $199,892	-64,900 Reduced 18.11%	293,532 $596,000
Q2 2020 Aug 14, 2020	BUY	$2.1 - $3.42 $109,435 - $178,223	52,112 Added 17.01%	358,432 $1.05 Million
Q1 2020 May 15, 2020	BUY	$2.31 - $4.43 $96,588 - $185,231	41,813 Added 15.81%	306,320 $732,000
Q4 2019 Feb 14, 2020	BUY	$2.82 - $12.9 $527,283 - $2.41 Million	186,980 Added 241.18%	264,507 $1.18 Million
Q3 2019 Nov 14, 2019	BUY	$4.33 - $11.64 $335,691 - $902,414	77,527 New	77,527 $802,000
Q4 2018 Feb 14, 2019	SELL	$21.32 - $46.34 $736,328 - $1.6 Million	-34,537 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$36.35 - $51.7 $636,488 - $905,267	-17,510 Reduced 33.64%	34,537 $1.63 Million
Q2 2018 Aug 14, 2018	BUY	$7.33 - $43.15 $205,203 - $1.21 Million	27,995 Added 116.39%	52,047 $1.86 Million
Q1 2018 May 15, 2018	BUY	$7.19 - $33.17 $172,933 - $797,804	24,052 New	24,052 $180,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $36.5M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.